View in EDS HTML Full Text PDF Full Text

MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma.
Authors: Jain, Ankit P.1,2, Patel, Krishna1,3, Pinto, Sneha1,4, Radhakrishnan, Aneesha1, Nanjappa, Vishalakshi1, Kumar, Manish1, Raja, Remya1,5, Patil, Arun H.1,2,4, Kumari, Anjali6, Manoharan, Malini6, Karunakaran, Coral6, Murugan, Saktivel6, Keshava Prasad, T. S.1,4, Chang, Xiaofei7, Mathur, Premendu Prakash2,8, Kumar, Prashant1, Gupta, Ravi6, Gupta, Rohit6, Khanna-Gupta, Arati6, Sidransky, David7
Source: Scientific Reports. 12/11/2019, Vol. 9 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-019-55208-5